Reproducible identification of the causative drug of a fixed drug eruption by oral provocation and lesional patch testing

Contact Dermatitis

Volumn 46, Issue 6, 2002, Pages 352-353

  Zedlitz, Sven ^a   Linzbach, Lars ^a   Kaufmann, Roland ^a   Boehncke, Wolf Henning ^a  

^a GOETHE UNIVERSITY MEDICAL SCHOOL   (Germany)

Author keywords

Cutaneous adverse drug reaction; Fixed drug eruption; Metamizol; Positive patch test

Indexed keywords

DICLOFENAC; DIPYRONE; LANSOPRAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; TETRAZEPAM;

ADULT; ALLERGY TEST; ARTICLE; CASE REPORT; DISEASE EXACERBATION; DRUG ERUPTION; DRUG TOLERABILITY; ERYTHEMA; HUMAN; LOW BACK PAIN; MALE; PAPULE; PATCH TEST; PROVOCATION TEST; REPRODUCIBILITY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DIAGNOSIS, DIFFERENTIAL; DIPYRONE; DRUG ERUPTIONS; HUMANS; LOW BACK PAIN; MALE; MIDDLE AGED; PATCH TESTS;

EID: 0036592702     PISSN: 01051873     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0536.2002.460606.x     Document Type: Article

References (7)

1. Current causes of fixed drug eruption in the UK
2. Fixed drug eruptions. Incidence, recognition, avoidance
3. Topical provocation of fixed drug eruption
4. Fixed eruptions. Causative drugs and challenge tests
5. Topical provocation of fixed drug eruption: A study of 30 patients
6. Drugs causing fixed eruptions
7. Generalized reaction after patch testing with metamizol